People with diabetes who were taking GLP-1 receptor agonist drugs such as tirzepatide and semaglutide had significantly lower ...

The global endoscopic closure devices market is projected to rise by $825.7m by 2029 at a compound annual growth rate of almost 8%.

After surgery, pain is expected and often subsides within a few weeks. But for around 20% of patients, persistent pain may continue for months or even years after a procedure, impacting quality of ...